Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | CA12 | O43570 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
| ▸ | CA4 | P22748 | 1/20 | 0.54 |
| ▸ | CA9 | Q16790 | 1/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | BCHE | P06276 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | CASP3 | P42574 | 1/20 | 0.47 |
| ▸ | CASP2 | P42575 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5496472 | 0.90 | ALDH1A1 (0.51) | CYP1A1POLBCYP1A2KMT2AALDH1A1 | |
| SCHEMBL3633228 | 0.82 | SMN1; SMN2 (0.64) | CYP1A1POLBCYP1A2CA12CA1 | |
| SCHEMBL13593266 | 0.82 | KMT2A (0.61) | CYP1A1POLBCYP1A2CA12CA1 | |
| SCHEMBL19382597 | 0.81 | ALDH1A1 (0.51) | CYP1A2KMT2AALDH1A1CYP2D6CYP2C9 | |
| SCHEMBL6009641 | 0.79 | SIRT2 (0.61) | CA12CA1CA2CA9CA14 | |
| SCHEMBL12325721 | 0.78 | KDM4C (0.64) | CYP1A1POLBCYP1A2CA12CA1 | |
| SCHEMBL12217983 | 0.76 | CYP1A1 (0.66) | CYP1A1POLBCYP1A2CA12CA1 | |
| Sulfuric Acid SCHEMBL3629891 | 0.75 | GAA (0.58) | CYP1A1POLBCYP1A2CA12CA1 | |
| SCHEMBL108096 | 0.75 | ERCC1 (0.62) | CYP1A1POLBCYP1A2KMT2AALDH1A1 | |
| Hydrochloric Acid SCHEMBL7323758 | 0.74 | POLB (0.51) | CYP1A1POLBCYP1A2CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9149530-B2 | Compositions and methods for enhancing active agent absorption | NEXUS PHARMA, INC. (US) | 2015-10-06 | — | — | US | disclosed |
| US-8426466-B2 | Compositions and methods for enhancing active agent absorption | NEXUS PHARMA, INC. (US) | 2013-04-23 | — | — | US | disclosed |
| US-20070269500-A1 | Compositions and methods for enhancing active agent absorption | NEXUS PHARMA, INC. | 2007-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070269500-A1 | Compositions and methods for enhancing active agent absorption | FABP2, SLC10A2, SI | CYP1A1 1282/4885POLB 1248/4885CYP1A2 775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.